Today's Gold Standard: Product Approval Demands Real-World Evidence

August 22, 2017

It is no longer enough to prove product quality, safety and efficacy, payers now want to know whether benefits will translate into the wider population of patients. Payers also want to see how the product compares to existing treatments rather than a placebo. This article examines key strategies for providing real-world evidence to help ensure your product will reach its full potential. 

Previous Flipbook
LIQUENT INSIGHT®: The Right Choice for Regulatory Information Management
LIQUENT INSIGHT®: The Right Choice for Regulatory Information Management

Read why 18 of the top 20 pharmaceutical companies are using a module of the LIQUENT InSight® platform as t...

Next Flipbook
Early Economic Models Pay Off
Early Economic Models Pay Off

Early-stage economic models can improve reimbursement approval -- here are three examples.

×

Speak to a Parexel® Biotech expert today!

First Name
Last Name
Job Title
Company Name
Country
Tell us how we can help
Thank you!
Error - something went wrong!